Navigation Links
USAID awards $5 million to CONRAD
Date:11/2/2010

Arlington, VA November 2, 2010 CONRAD, leaders in reproductive health and HIV prevention research, today announced a $5 million award from the US Agency for International Development (USAID). The grant will fund research and development of vaginal rings that are contraceptive and also prevent HIV and STI infections.

USAID provided funding for the CAPRISA 004 trial of tenofovir gel, conducted by the Centre for Programme Research for AIDS in South Africa (CAPRISA), which was the first study to show that a vaginal gel can reduce the risk of HIV and herpes infection in women. CONRAD manufactured and provided the tenofovir gel for the study. Tenofovir gel was found to be 39% effective in reducing a woman's risk of becoming infected with HIV during sex and 51% effective in preventing genital herpes infections in the women participating in the trial. The FDA recently granted Fast Track approval designation for tenofovir gel, pending confirmatory results from the NIH-sponsored Phase IIB study, MTN-003, known as VOICE (Vaginal and Oral Interventions to Control the Epidemic.) CONRAD's pre-clinical and product development team are evaluating products that include combination gels and barrier methods, such as an intravaginal ring impregnated with tenofovir and a contraceptive that is the subject of this grant.

"Thanks to USAID, we have been able to manufacture the first product to reduce women's risk of HIV and herpes," said Henry Gabelnick, Executive Director of CONRAD. "This award will allow us to expedite the evaluation of a dual-protection technology that promises to be a breakthrough in the simultaneous prevention of unplanned pregnancies and HIV infection."

Almost half of all pregnancies worldwide, estimated to be over 100 million annually, are unintended. In sub-Saharan Africa in particular, low contraceptive use rates are reflected by high fertility rates, and thus high infant and maternal mortality rates. This area of the world is also the core of the AIDS epidemic, with 22.4 million people infected with HIV, many of them young women. Poverty, malnutrition, lack of education and gender inequality fuel both unintended pregnancies and HIV transmission; therefore, there is an urgent need to develop dual protection technologies.

"We strongly support research that focuses on women's health in developing countries and a dual-protection product that can prevent unintended pregnancies as well as HIV and other STIs can make an enormous difference," said Dr. Judy Manning with USAID. "CONRAD has been on the forefront of this technology and we are proud to support their work."


'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
CONRAD
Source:Eurekalert

Related biology news :

1. USAID grant awarded to improve food security in Africa
2. USDA awards Virginia Tech $3.8 million to stimulate eastern US wine industry
3. NSF awards new projects for plant genome research
4. Landenberger Foundation awards grant to Scripps Florida scientist to study HIV
5. NSF awards $3.75 million grant to New York Plant Genome Consortium for the creation of BigPlant v1.0
6. NSF awards grants for research on coupled natural and human systems
7. NSF awards grants to study effects of ocean acidification
8. USDA awards grant to GSU professor to study childhood obesity dynamics
9. DFG awards 4 young scientists 2010 Bernd Rendel Prize
10. MARC travel awards announced for the ASBMR 2010 annual meeting
11. Knome Awards Human Exome Sequencing and Analysis to Biomedical Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2016)... India , January 21, 2016 ... According to a new market research report "Emotion Detection ... and Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020", published by ... is expected to reach USD 22.65 Billion by ...
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
(Date:1/18/2016)... Jan. 18, 2016  Extenua Inc., a pioneering ... the use and access of ubiquitous on-premise and ... with American Cyber.  ... leading transformational C4ISR and Cyber initiatives in support ... latest proven technology solutions," said Steve Visconti ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... Feb. 10, 2016  IsoRay, Inc. (NYSE MKT: ISR), ... and medical radioisotope applications for the treatment of prostate, ... announced its financial results for the second quarter and ... 2015. --> --> ... of fiscal 2016, which ended December 31, 2015, a ...
(Date:2/10/2016)... Texas (PRWEB) , ... February 10, 2016 , ... ... centers across three states, announced today the promotion of two long-standing principal investigators ... Chief of Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... their comprehensive training and support program, Sonalinkā„¢ remote monitoring. The inaugural launch of ... on Friday, February 5th, connecting Dr. Samuel Peretsman to a HIFU technical expert ...
Breaking Biology Technology: